Bradley J. Huth, Dennis M. Sopka, Jay Reiff, Lydia T. Komarnicky-Kocher
{"title":"Partial Breast Irradiation: Is This a Viable Option?","authors":"Bradley J. Huth, Dennis M. Sopka, Jay Reiff, Lydia T. Komarnicky-Kocher","doi":"10.1053/j.sembd.2007.10.003","DOIUrl":"https://doi.org/10.1053/j.sembd.2007.10.003","url":null,"abstract":"<div><p><span><span>In the treatment of early invasive and </span>in situ breast carcinomas<span>, lumpectomy<span> followed by whole breast radiation are generally accepted as standard of care in breast conservation. Long-term data from early breast conservation trials has shown that most local failures occur in close proximity to the tumor bed. This has been observed in both radiated and unradiated breasts treated with breast conservation techniques, suggesting that occult multifocal disease is less ominous than once believed. Improvements in breast imaging and </span></span></span>radiation treatment planning<span><span> and delivery allow the experienced radiation oncologist to deliver high doses of radiation to the region of the tumor bed alone in less than 2 weeks. Preliminary data suggests that this abbreviated course of radiation offers cosmetic and disease control outcomes equal to that of traditional whole breast radiation in selected populations. This article reviews current techniques, outcomes of </span>clinical trials<span>, and novel techniques in partial breast radiation for early and locally recurrent breast carcinomas.</span></span></p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 4","pages":"Pages 152-161"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.10.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138386279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gordon F. Schwartz, Umberto Veronesi, Krishna B. Clough, J.M. Dixon, Ian S. Fentiman, Sylvia H. Heywang-Köbrunner, Roland Holland, Kevin S. Hughes, Richard Margolese, Ivo A. Olivotto, Juan P. Palazzo, Lawrence J. Solin, Consensus Conference Committee
{"title":"Consensus Conference on Breast Conservation","authors":"Gordon F. Schwartz, Umberto Veronesi, Krishna B. Clough, J.M. Dixon, Ian S. Fentiman, Sylvia H. Heywang-Köbrunner, Roland Holland, Kevin S. Hughes, Richard Margolese, Ivo A. Olivotto, Juan P. Palazzo, Lawrence J. Solin, Consensus Conference Committee","doi":"10.1053/j.sembd.2007.10.005","DOIUrl":"https://doi.org/10.1053/j.sembd.2007.10.005","url":null,"abstract":"","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 4","pages":"Pages 178-185"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.10.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138411466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Challenges in the Management of Metastatic Breast Cancer","authors":"Homayoon Sanati MD, MS","doi":"10.1053/j.sembd.2007.10.009","DOIUrl":"10.1053/j.sembd.2007.10.009","url":null,"abstract":"<div><p><span>Breast cancer is the most common cancer in women in the United States. About 6% of newly diagnosed breast cancer cases present with metastatic disease, and one-third of women diagnosed with earlier stage breast cancer develop metastatic disease. Management of </span>metastatic breast cancer<span><span><span> (MBC) continues to be challenging, and MBC remains essentially an incurable disease. Treatment of MBC is individualized for each patient, and it is often based on patient’s preferences, comorbidities, performance status, </span>prognostic factors, menopausal status, and prior history of treatments. Risk assessment is the first step in the management of MBC. Factors that can affect the prognosis (hormone receptor status, HER-2 expression status, disease-free interval, tumor burden, site of metastasis, and vital organ involvement) are considered before start of the treatments. Women with hormone responsive disease and stable bony metastasis are often treated with hormonal therapies and </span>bisphosphonates<span><span><span>. Women with hormone-unresponsive disease or fast-growing tumors are treated with systemic chemotherapy with or without a targeted therapy agent. Metastasis to the brain, </span>spinal cord compression<span>, pleural effusion, </span></span>hypercalcemia<span>, and pancytopenia secondary to bone marrow infiltration are common complications of MBC, and the management of each complication will be briefly discussed. Future research to identify molecular prognostic markers and to evaluate various strategies for optimal management of MBC is needed.</span></span></span></p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 3","pages":"Pages 128-133"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.10.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57942533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unusual Benign Breast Lesions","authors":"Ashley Kempf BS, Karen Lane MD","doi":"10.1053/j.sembd.2007.10.008","DOIUrl":"10.1053/j.sembd.2007.10.008","url":null,"abstract":"<div><p>There are a variety of unusual breast lesions<span> that may mimic cancer on physical examination and imaging. Although the optimal management of many of these lesions remains debated in the literature, the developing modality of magnetic resonance imaging continues to provide clues to delineate these benign lesions from breast cancer. This review article discusses some of the unusual benign breast lesions that we have encountered and recommends the appropriate diagnostic work-up and treatment options for patients with such lesions.</span></p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 3","pages":"Pages 110-114"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.10.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57942465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Irina Yermilov MD, MS , Melinda A. Maggard MD, MSHS
{"title":"Defining Quality of Care for Breast Cancer: Clinical Challenges","authors":"Irina Yermilov MD, MS , Melinda A. Maggard MD, MSHS","doi":"10.1053/j.sembd.2007.10.011","DOIUrl":"10.1053/j.sembd.2007.10.011","url":null,"abstract":"<div><p>Breast cancer is the second most common oncologic diagnosis in women; however, these patients only receive 86% of the basic recommended care. Understanding how high-quality breast cancer care is defined and measured is the first step toward improving the care we provide. In addition, regulatory agencies and some payers are requiring that certain measures of quality are reported and publicized. The Centers for Medicare and Medicaid Services offers higher payments to hospitals and providers with better quality care, ie, pay-for-performance. As the demands on physicians to measure quality grow, it is imperative that we are well informed on the topic and participate in the current debates and future policy implications. In this article, we describe the methods used to measure the quality of care, as well as the challenges to measuring and providing high-quality breast cancer care.</p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 3","pages":"Pages 121-127"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.10.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57943205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Managing Menopausal Symptoms in Breast Cancer Survivors: Focus on Hot Flashes","authors":"Edith Caroline Smith MSN, CNM, WHCNP","doi":"10.1053/j.sembd.2007.10.010","DOIUrl":"10.1053/j.sembd.2007.10.010","url":null,"abstract":"<div><p>Breast cancer survivors usually experience menopausal symptoms<span> to a far greater degree than women who have not had breast cancer. Choices are limited, however, in what can be offered in the way of safe and effective therapy. This review article discusses the options available to breast cancer survivors for the treatment<span> of the most common and bothersome of menopausal symptoms: hot flashes. Traditional and complementary approaches are discussed with attention to benefits and risks as they relate to treating women with a personal history of breast cancer.</span></span></p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 3","pages":"Pages 115-120"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.10.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57942689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Linda J. Warren Burhenne MD, FRCPC, Andrew J. Coldman PhD, Lisa Kan MSc
{"title":"Organized Breast Cancer Screening in British Columbia: The Screening Mammography Program of British Columbia","authors":"Linda J. Warren Burhenne MD, FRCPC, Andrew J. Coldman PhD, Lisa Kan MSc","doi":"10.1053/j.sembd.2007.09.005","DOIUrl":"10.1053/j.sembd.2007.09.005","url":null,"abstract":"<div><p>The first organized breast cancer service screening program in Canada was established in 1988 in British Columbia. The pilot project was successful in showing that screening could be conducted at a unit cost of US$38; now US$41. Screening is conducted in dedicated centers and diagnostic work-ups done in the community. The current annual volume is 235,000. Stepwise expansion is ongoing and is determined by community specific service requirements. Prognostic factors of cancers detected consistently exceed internationally recommended targets. Since the inception of the program the age standardized breast cancer mortality rate per 100,000 has dropped in British Columbia from the highest to the lowest in Canada for provinces with similar populations.</p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 2","pages":"Pages 83-88"},"PeriodicalIF":0.0,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.09.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57942279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of the Impact of Service Screening: The Florence City Programme (1990–1996)","authors":"Eugenio Paci MD","doi":"10.1053/j.sembd.2007.09.002","DOIUrl":"10.1053/j.sembd.2007.09.002","url":null,"abstract":"<div><p><span>In Europe, the challenge today is the evaluation of the impact of mammography service screening. Here, we analyze data of the Florence City Breast Cancer Screening Programme from 1990 to 1996. Breast cancer cases registered in women aged 50 to 69 were partitioned by diagnostic modality and screening invitation. The cumulative number of breast cancer deaths within cases was calculated to estimate the rates of cancers proving fatal within a period of 8 years of observation (incidence-based mortality). For women who were not yet invited at the time of diagnosis, there was a 41% significant mortality reduction (RR = 0.59, 95% CI: 0.42-0.82) when compared with the data in 1985 to 1986. In those invited, there was a significant 55% mortality reduction (RR = 0.45, 95% CI: 0.32-0.61). Percentages of </span>breast conserving surgery by screening modality were higher in cases occurring in invited women and are considered an important outcome of service screening. This study is one of the first examples of the evaluation of service screening and supports the conclusion that screening is contributing to the reduction of mortality from breast cancer.</p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 2","pages":"Pages 64-67"},"PeriodicalIF":0.0,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.09.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57942003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephen W. Duffy , Tony H.H. Chen , Amy M.F. Yen , Laszlo Tabar , Rhian Gabe , Robert A. Smith
{"title":"Methodologic Issues in the Evaluation of Service Screening","authors":"Stephen W. Duffy , Tony H.H. Chen , Amy M.F. Yen , Laszlo Tabar , Rhian Gabe , Robert A. Smith","doi":"10.1053/j.sembd.2007.09.003","DOIUrl":"10.1053/j.sembd.2007.09.003","url":null,"abstract":"<div><p><span>With the conclusive evidence from randomized controlled trials of the efficacy of mammographic screening in reducing mortality from breast cancer, the emphasis for the </span>public health community has shifted to evaluation of service screening programs. Here, we briefly review the major approaches available for mortality-based evaluation of breast cancer screening programs and identify some design and analytic issues arising from these methodologic approaches. If care is taken to avoid or correct for biases, reliable evaluation of the mortality effect of service screening is possible. Results suggest that service screening programs are achieving breast cancer mortality reductions at least as great, and sometimes greater, as those observed in the trials.</p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 2","pages":"Pages 68-71"},"PeriodicalIF":0.0,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.09.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57942063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carrie N. Klabunde PhD, Rachel Ballard-Barbash MD, MPH, International Breast Cancer Screening Network
{"title":"Evaluating Population-Based Screening Mammography Programs Internationally","authors":"Carrie N. Klabunde PhD, Rachel Ballard-Barbash MD, MPH, International Breast Cancer Screening Network","doi":"10.1053/j.sembd.2007.09.007","DOIUrl":"10.1053/j.sembd.2007.09.007","url":null,"abstract":"<div><p>This report describes the purpose and activities of the International Breast Cancer Screening Network (IBSN), a voluntary consortium of countries that focuses on collaborative research to identify and promote efficient and effective approaches to breast cancer control worldwide through population-based screening mammography<span>. Sponsored by the U.S. National Cancer Institute, the IBSN was established in 1988 with 11 participating countries. By 2005, membership had grown to 27 countries. Recent IBSN efforts have involved gathering information on program organization and quality assurance activities, evaluating measures and methodologies for assessing screening mammography performance and outcomes, and examining the information that programs are providing to women as a means of facilitating informed decision-making about the benefits and risks of screening mammography. The ongoing IBSN effort demonstrates that, despite marked differences in health care systems, international collaborative work can contribute new knowledge to the monitoring and evaluation of organized, population-based screening mammography programs, and can identify potential areas for improvement in screening performance in practice.</span></p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"10 2","pages":"Pages 102-107"},"PeriodicalIF":0.0,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2007.09.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27472023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}